English | Español
Patient Daily Report | May 23, 2023

Dr. Janet Maynard: new FDA-approved drug will 'provide an additional safe and effective option for women' experiencing hot flashes
Patient Daily | May 22, 2023

Vizzia Technologies Achieves SOC 2 Type II Compliance Certification for RTLS
Pacient Daily | May 22, 2023

Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
Pacient Daily | May 22, 2023

Clinical ink Work Demonstrating Technology Sensitivity to Parkinson’s Disease Published in Nature
Patient Daily | May 22, 2023

Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
Pacient Daily | May 18, 2023

How OR Automation Keeps Surgeons Busy (and Revenues Up)
Patient Daily Report | May 17, 2023

DBV Technologies CEO: 'We are thrilled to see the EPITOPE Phase 3 data published in the New England Journal of Medicine'
Patient Daily Report | May 16, 2023

Oxford professor on IVF procedure to prevent inheritable diseases: 'So far, the clinical experience with mitochondrial replacement therapy has been encouraging'

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’